LIVN Stock Recent News

LivaNova is clearly doing better in weaker segments and technical profitability has actually been reached now on an operating level. Neuromodulation has been seeing slowing unit growth as seen by signs in our last coverage, but the bigger issue is that its contribution is declining on R&D expenses.

LivaNova PLC (NASDAQ:LIVN ) Q2 2022 Earnings Conference Call August 3, 2022 8:00 AM ET Company Participants Matthew Dodds - SVP, Corporate Development Damien McDonald - CEO & Director Alex Shvartsburg - CFO Conference Call Participants Michael Polark - Wolfe Research Frederick Wise - Stifel, Nicolaus & Company Michael Matson - Needham & Company Adam Maeder - Piper Sandler & Co. Zachary Weiner - Jefferies Anthony Petrone - Mizuho Americas Operator Good day, ladies and gentlemen, and welcome to the LivaNova PLC Second Quarter 202 Earnings Conference Call. [Operator Instructions].

LivaNova (LIVN) delivered earnings and revenue surprises of 3.92% and 2.61%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

LivaNova PLC (NASDAQ:LIVN ) Q1 2022 Results Earnings Conference Call May 4, 2022 8:00 AM ET Company Participants Matthew Dodds - Senior Vice President, Corporate Development Damien McDonald - Chief Executive Officer Alex Shvartsburg - Chief Financial Officer Conference Call Participants Rick Wise - Stifel Financial Mike Polark - Wolfe Research Mike Matson - Needham & Company, LLC Adam Maeder - Piper Sandler Philip Coover - Goldman Sachs Zachary Weiner - Jefferies LLC Operator Good day, ladies and gentlemen, and welcome to the LivaNova PLC First Quarter 2022 Earnings Conference Call. [Operator Instructions].

LivaNova (LIVN) delivered earnings and revenue surprises of -7.69% and 3.09%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?